The Tuberculosis epidemic in the Region has reached emergency proportions. Currently, 22 high burden countries worldwide are responsible for 80% of the total global TB burden and of which 9 are in the African Region.

Of the 15 countries with the highest estimated TB incidence rates per capita, 12 are in Africa. In 2007, TB notifications from the Region accounted for 30% of all notified cases in the world. The Region was the worst of three epidemiological regions where TB incidence was still rising. The emergence of multi-drug Resistance (MDR-TB) and Extensively Drug Resistance (XDR TB) has made more difficult TB case management. Access to 2nd line drugs for MDR/XDR-TB cases is still a big challenge because of the issue of affordability by countries.

As a result of the implementation of the Directly Observed Treatment Short Course (DOTS) and the new Stop TB Strategy, 10 countries reached or exceeded the 70% case detection rate for new smear-positive cases and eight countries have reached or exceeded the treatment success rate target (85%). Scaling up of collaborative TB/HIV activities has been ongoing in most TB/HIV high prevalence countries. As a result, TB patients counseled and tested for HIV increased from 22% to 38 % between 2006 and 2008 . The prevention and management of MDR-TB has improved in countries: 36 countries have capacity for TB culture and Drug Susceptibility Testing(DST) services. However, in the African Region, the TB prevalence has increased from 333/100,000 in 1990 to 547/100,000 in 2008 while the disease incidence has likewise increased from 162 to 363/100,000 population between 1990 and 2008.

Some of the key challenges to be addressed relate to health system strengthening and especially the human resource and laboratory as well as, the implementation of TBHIV collaborative activities, the threat of drug resistant TB especially Multi-drug resistant (MDR-TB) and Extensively Drug Resistant (XDR-TB).

For more information please contact:

altDr Bah Keita
Cite de Djoue
PO 06 Brazzaville
Tel.: +242 7654550/ +242 06 6441244
Email : This e-mail address is being protected from spambots. You need JavaScript enabled to view it


Related links:

  1. WHO Stop TB Strategy
  2. OMS – Stratégie Halte à la tuberculose